Financial Times: Global pharmaceutical companies are increasingly looking to China as patents on best-selling medicines expire.
…Now the pharmaceutical sector is being pulled into the fray. On May 21, Republican congressman John Moolenaar asked Treasury secretary Scott Bessent to include biotechnology in a 2025 national security law aimed at restricting US investment into countries including China…